(Q35906324)

11 August 2017

1 reference

title

Statin-associated peripheral neuropathy: review of the literature (English)

1 reference

11 August 2017

peripheral neuropathy

1 reference

Pang H Chong

1

1 reference

11 August 2017

Alexandra Boskovich

series ordinal

2

1 reference

11 August 2017

Natasa Stevkovic

series ordinal

3

1 reference

11 August 2017

Russell E Bartt

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

24

1 reference

11 August 2017

9

1 reference

11 August 2017

1194-1203

1 reference

Clinically relevant differences between the statins: implications for therapeutic selection

11 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Drug treatment of lipid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Four cases of tendinopathy in patients on statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Peripheral neuropathy associated with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Statins and peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Pleiotropic effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Lovastatin, isoprenes, and myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.13.1194.38084

10.1592/PHCO.24.13.1194.38084

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference